REQUEST A DEMO
Total
USD $0.00
Search more companies

Holly Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Holly Drugs Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Holly Drugs Private Limited is an unlisted company, incorporated on 18/07/2007. It has its registered office in the State of Chandigarh, India. Company's corporate identification number (CIN) is U24232CH2007PTC030879 and registration number is 030879. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Sco 392, 2Nd Floor Sector 37D
Chandigarh; Punjab; Postal Code: 160036

Contact Details: Purchase the Holly Drugs Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Holly Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Holly Drugs Private Limited report to view the information.
Incorporation Date:
July 18, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Holly Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
34.34%
Total operating revenue
34.34%
Operating profit (EBIT)
40.2%
EBITDA
24.97%
Net Profit (Loss) for the Period
33.78%
Total assets
-10.39%
Total equity
9.9%
Operating Profit Margin (ROS)
0%
Net Profit Margin
0%
Return on Equity (ROE)
1.69%
Debt to Equity Ratio
-244.72%
Quick Ratio
0.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?